JPS5721314A - Composition for pharmaceutical preparation free from bitter taste, and its preparation - Google Patents

Composition for pharmaceutical preparation free from bitter taste, and its preparation

Info

Publication number
JPS5721314A
JPS5721314A JP9478080A JP9478080A JPS5721314A JP S5721314 A JPS5721314 A JP S5721314A JP 9478080 A JP9478080 A JP 9478080A JP 9478080 A JP9478080 A JP 9478080A JP S5721314 A JPS5721314 A JP S5721314A
Authority
JP
Japan
Prior art keywords
bitter taste
water
waxy substance
preparation
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9478080A
Other languages
Japanese (ja)
Other versions
JPS6029682B2 (en
Inventor
Tamio Hikosaka
Yu Konno
Masayoshi Ariga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP55094780A priority Critical patent/JPS6029682B2/en
Priority to FR8113160A priority patent/FR2486398A1/en
Priority to DE19813126258 priority patent/DE3126258A1/en
Priority to GB8121487A priority patent/GB2081092B/en
Publication of JPS5721314A publication Critical patent/JPS5721314A/en
Publication of JPS6029682B2 publication Critical patent/JPS6029682B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: To prepare the titled composition having high rate of eluation of the active component, by dispersing a water-soluble drug having bitter taste together with a water-swellable high polymer in molten waxy substance, and solidifying the dispersion.
CONSTITUTION: A water-soluble drug having bitter taste (e.g. talampicillin hydrochloride, indenolol hydrochloride, etc.) is dispersed together with a water-swellable polymer (e.g. L-hydroxypropylcellulose, carboxymethylcellulose, etc.) in a molten waxy substance (e.g. carnauba wax, beeswax, hardened oil, etc.), and solidified to obtain a pharmaceutical preparation composition free from bitter taste. The amount of the waxy substance is pref. ≥3 pts.wt. per 1 pt.wt. of the drug, and that of the polymer is pref. 0.05W0.3pt.wt.per 1pt.wt. of the waxy substance. It may be incorporated with a diluent such as lactose, and optionally with a colorant, perfume, etc., and powdered or granulated.
COPYRIGHT: (C)1982,JPO&Japio
JP55094780A 1980-07-11 1980-07-11 Bitter-free pharmaceutical composition and method for producing the same Expired JPS6029682B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP55094780A JPS6029682B2 (en) 1980-07-11 1980-07-11 Bitter-free pharmaceutical composition and method for producing the same
FR8113160A FR2486398A1 (en) 1980-07-11 1981-07-03 COMPOSITION FOR PREPARATION WITH NO AMERTUME
DE19813126258 DE3126258A1 (en) 1980-07-11 1981-07-03 NON-BITTER DRUG PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
GB8121487A GB2081092B (en) 1980-07-11 1981-07-13 Improving taste acceptability of pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55094780A JPS6029682B2 (en) 1980-07-11 1980-07-11 Bitter-free pharmaceutical composition and method for producing the same

Publications (2)

Publication Number Publication Date
JPS5721314A true JPS5721314A (en) 1982-02-04
JPS6029682B2 JPS6029682B2 (en) 1985-07-12

Family

ID=14119597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55094780A Expired JPS6029682B2 (en) 1980-07-11 1980-07-11 Bitter-free pharmaceutical composition and method for producing the same

Country Status (4)

Country Link
JP (1) JPS6029682B2 (en)
DE (1) DE3126258A1 (en)
FR (1) FR2486398A1 (en)
GB (1) GB2081092B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58216118A (en) * 1982-06-11 1983-12-15 Morishita Seiyaku Kk Amino acid pharmaceutical preparation composition and its preparation
JPS62258327A (en) * 1986-05-01 1987-11-10 Toyama Chem Co Ltd Production of coated powdery agent and coated granular agent
JP2001288117A (en) * 2000-04-05 2001-10-16 Otsuka Pharmaceut Co Ltd Composition for medicinal preparation
US6368635B1 (en) 1991-04-19 2002-04-09 Takeda Chemical Industries, Ltd. Gastrointestinal mucosa-adherent matrixes pharmaceutical preparations and a coating composition

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
NL193682C (en) * 1987-05-14 2000-07-04 Glaxo Group Ltd Coated Cefuroxime Maxetil Composition.
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
ES2202302T3 (en) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. MASSABLE COMPOSITION THAT FREE A PHARMACO.
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ES2194863T3 (en) * 1992-11-30 2003-12-01 Kv Pharm Co PHARMACEUTICAL MATERIALS WITH MASK OF FLAVOR.
FR2702375B1 (en) * 1993-03-08 1995-05-05 Virbac Laboratoires Progressive release microcapsules, process for their preparation and pharmaceutical or veterinary compositions containing them.
BE1009257A3 (en) * 1995-03-21 1997-01-07 Universiteit Gent Lab Voor Far Pharmaceutical matrix.
AUPN862596A0 (en) * 1996-03-12 1996-04-04 F.H. Faulding & Co. Limited Pharmaceutical compositions
WO2001064190A1 (en) 2000-03-01 2001-09-07 Eisai Co., Ltd. Rapidly disintegrable tablet containing polyvinyl alcohol
NZ603545A (en) 2010-04-12 2013-10-25 Zhaveri Pharmakem Pvt Ltd S Ciprofloxacin dry syrup composition
CN103877027B (en) * 2014-03-17 2016-01-27 广东药学院 A kind of CEFUROXIME AXETIL hot melt coated composition and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1550359A (en) * 1975-08-07 1979-08-15 Beecham Group Ltd Antibiotic compositions for oral administration
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
JPS52120976A (en) * 1976-04-06 1977-10-11 Fuji Photo Film Co Ltd Manufacture of capsule having wall of waxy material

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58216118A (en) * 1982-06-11 1983-12-15 Morishita Seiyaku Kk Amino acid pharmaceutical preparation composition and its preparation
JPH0322367B2 (en) * 1982-06-11 1991-03-26 Morishita Pharma
JPS62258327A (en) * 1986-05-01 1987-11-10 Toyama Chem Co Ltd Production of coated powdery agent and coated granular agent
US6368635B1 (en) 1991-04-19 2002-04-09 Takeda Chemical Industries, Ltd. Gastrointestinal mucosa-adherent matrixes pharmaceutical preparations and a coating composition
JP2001288117A (en) * 2000-04-05 2001-10-16 Otsuka Pharmaceut Co Ltd Composition for medicinal preparation
JP4570725B2 (en) * 2000-04-05 2010-10-27 大塚製薬株式会社 Composition for pharmaceutical preparation

Also Published As

Publication number Publication date
FR2486398A1 (en) 1982-01-15
GB2081092A (en) 1982-02-17
GB2081092B (en) 1985-01-23
FR2486398B1 (en) 1983-12-09
DE3126258A1 (en) 1982-08-05
JPS6029682B2 (en) 1985-07-12

Similar Documents

Publication Publication Date Title
JPS5721314A (en) Composition for pharmaceutical preparation free from bitter taste, and its preparation
EP0670716B1 (en) Tastemasked pharmaceutical materials
AU670555B2 (en) Inhalation powders and method of manufacturing them
JPS56140915A (en) Pharmaceutical preparation for solid drug
CA2270975A1 (en) Stabilized sustained release tramadol formulations
BG102228A (en) Medicamentous form with controlled release of slightly soluble medicamentous substances
CA2024291A1 (en) Dosage device and preparation and use thereof
HUP0300593A2 (en) Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
NO971965L (en) A pharmaceutical composition containing a fusible carrier and process for its preparation
JPS61143316A (en) Preparation of stable tablet
NO170753C (en) PROCEDURE FOR THE PREPARATION OF SOLID PHARMACEUTICAL PREPARATIONS WITH DELAYED RELEASE
EP0370761A3 (en) Process of preparing hard confectionery products containing mainly xylitol
HUP9800857A2 (en) Pesticide compositions, method for preparing and using thereof
DE4342568A1 (en) Chewing gum contg. caffeine - used as substitute for coffee, tea, cola, etc. and to control fatigue and migraine
KR100364094B1 (en) Preparation of chewable tablets based on combinations of Troxertin, Calcium Carbonate, Calcium Phosphate, Arginine Aspartate, Arginine Glutamate, Amoxicillin, Calcium Carbonate and Magnesium Carbonate, and combinations of Aluminum Hydroxide and Magnesium Hydroxide Way
CA2121904A1 (en) Dimeticon pastilles
HU901386D0 (en) Antidotes comprising 2,3-substituted 1,8-naphthyridines, antidoted herbicidal compositions, and process for preparation of the active ingredients
EP0021102A2 (en) Bonbon with a herbal core and process for its preparation
Said et al. Sustained release from inert matrices I. Effect of macrocrystalline cellulose on aminophylline and theophylline release
JPS6034908A (en) Edible chewing gum type composition for oral cavity
JPS63243035A (en) Bitter drug-containing solid agent and production thereof
JPS52107033A (en) Method of manufacturing slurry-type water dispersed paint
JPS5537119A (en) Preparation of instant creaming powder
JPS559757A (en) Ice cream
JPS61200909A (en) Long-acting composition for filling in capsule